C82.29
Follicular lymphoma grade III, unspecified, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically within the lymph nodes. Grade III indicates an aggressive form of this cancer, characterized by rapid growth and a higher likelihood of spreading to other parts of the body. When described as extranodal and affecting solid organs, it refers to the lymphoma appearing outside the typical lymph node locations, involving tissues like the spleen, liver, or other organs. Recognizing and understanding this diagnosis can help patients better grasp their condition and the importance of medical treatment.
Causes & Symptoms
Clinical Causes: Genetic mutations within lymphatic cells Exposure to certain environmental toxins or chemicals History of autoimmune diseases Previous radiation therapy or chemotherapy Age-related changes in immune function Infections that may trigger lymphocyte changes
Key Symptoms: New or enlarging painless lymph node swelling Unexplained weight loss Persistent fatigue or tiredness Fever that recurs or persists Night sweats Itching without an apparent cause Swelling or discomfort in the abdomen due to organ involvement Signs related to affected organs, such as jaundice if the liver is involved
Diagnostic & Treatment
Diagnosis Path: Diagnosing follicular lymphoma grade III involves a combination of clinical evaluation and laboratory tests. Key steps include: - Physical examination to identify enlarged lymph nodes or organ swelling - Imaging tests such as CT scans or PET scans to assess the extent and spread - Biopsy of an affected lymph node or organ tissue to examine cellular characteristics - Histopathological analysis to determine the grade of the lymphoma - Laboratory blood tests to evaluate overall health and organ function These diagnostic measures help classify the lymphoma accurately, guiding treatment decisions.
Treatment Protocols: Treatment options for follicular lymphoma grade III with extranodal and solid organ involvement typically involve a multi-faceted approach, tailored to the patient's overall health and the disease stage. Common strategies include: - Chemotherapy regimens to target rapidly dividing cancer cells - Immunotherapy to boost the body's immune response against the lymphoma - Targeted therapies that specifically attack lymphoma cells - Radiation therapy for localized disease or symptom relief - Stem cell transplantation in select cases, especially if initial treatments are not effective While treatment can be complex, advances in medical science continue to improve outcomes and quality of life for patients with this condition.
Clinical Advice & FAQs
Billing Guidance
Is C82.29 a billable ICD-10 code?
Yes, C82.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.29?
Clinical documentation must specify the nature of Follicular lymphoma grade III, unspecified, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference